1
|
Bermudo-Gallaguet A, Ariza M, Agudelo D, Camins-Vila N, Boldó M, Peters S, Sawicka AK, Dacosta-Aguayo R, Soriano-Raya JJ, Via M, Clemente IC, García-Molina A, Durà Mata MJ, Torán-Monserrat P, Erickson KI, Mataró M. Effects of Mindfulness and Exercise on Growth Factors, Inflammation, and Stress Markers in Chronic Stroke: The MindFit Project Randomized Clinical Trial. J Clin Med 2025; 14:2580. [PMID: 40283415 PMCID: PMC12028070 DOI: 10.3390/jcm14082580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2025] [Revised: 03/21/2025] [Accepted: 04/02/2025] [Indexed: 04/29/2025] Open
Abstract
Background/Objectives: Stroke often leads to persistent cognitive and emotional impairments, which rehabilitation may mitigate. However, the biological mechanisms underlying such improvements remain unclear. This study investigated whether supplementing computerized cognitive training (CCT) with mindfulness-based stress reduction (MBSR) or physical exercise (PE) modulated biomarkers of neuroplasticity, inflammation, and stress in patients with chronic stroke compared to CCT alone. We also explored whether biomarker changes mediated or correlated with behavioral improvements. Methods: In a three-arm, single-blind, randomized controlled trial (NCT04759950), 141 patients with chronic stroke were randomized (1:1:1) to MBSR+CCT, PE+CCT, or CCT-only for 12 weeks. Plasma levels of brain-derived neurotrophic factor (BDNF), insulin-like growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), C-reactive protein (CRP), interleukin-6 (IL-6), and cortisol were measured at baseline and post-intervention. Cognitive, mental health, mindfulness, and fitness outcomes were also assessed. Between- and within-group changes were analyzed using ANCOVA and paired t-tests. Per-protocol and complete-case analyses were conducted. Results: Among the 109 participants with ≥80% adherence, the only significant between-group difference was for VEGF: it remained stable in the MBSR+CCT group but declined in PE+CCT and CCT-only. Within-group analyses showed significant decreases in cortisol in MBSR+CCT and PE+CCT, while IGF-1 levels declined across all groups. In contrast, BDNF, IL-6, and CRP did not show significant changes, and biomarker changes were not significantly associated with behavioral improvements. Complete-case analysis (n = 126) yielded similar findings. Conclusions: Our findings suggest that combining MBSR or PE with CCT may modulate certain biological processes relevant to stroke recovery. MBSR may help maintain VEGF levels, which could support vascular health, while MBSR and PE may contribute to lowering cortisol levels. However, since no clear association with behavioral improvements was found, further research is needed to determine the clinical relevance of these biomarker changes in stroke recovery.
Collapse
Affiliation(s)
- Adrià Bermudo-Gallaguet
- Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB), Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; (A.B.-G.); (M.A.); (D.A.); (S.P.); (J.J.S.-R.); (M.V.); (I.C.C.)
- Institut de Neurociències, Universitat de Barcelona, Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain
- Institut de Recerca Sant Joan de Déu Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain
| | - Mar Ariza
- Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB), Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; (A.B.-G.); (M.A.); (D.A.); (S.P.); (J.J.S.-R.); (M.V.); (I.C.C.)
| | - Daniela Agudelo
- Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB), Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; (A.B.-G.); (M.A.); (D.A.); (S.P.); (J.J.S.-R.); (M.V.); (I.C.C.)
| | - Neus Camins-Vila
- Institut Nacional d’Educació Física de Catalunya (INEFC), Universitat de Barcelona (UB), 08038 Barcelona, Spain;
| | - Maria Boldó
- Servei de Rehabilitació, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, 08916 Badalona, Spain; (M.B.); (M.J.D.M.)
- Institut de Recerca Germans Trias i Pujol (IGTP), Campus Can Ruti, 08916 Badalona, Spain; (R.D.-A.); (A.G.-M.); (P.T.-M.)
| | - Sarah Peters
- Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB), Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; (A.B.-G.); (M.A.); (D.A.); (S.P.); (J.J.S.-R.); (M.V.); (I.C.C.)
| | - Angelika Katarzyna Sawicka
- Applied Cognitive Neuroscience Lab, Department of Neurophysiology, Neuropsychology and Neuroinformatics, Medical University of Gdansk, 80-210 Gdansk, Poland;
| | - Rosalia Dacosta-Aguayo
- Institut de Recerca Germans Trias i Pujol (IGTP), Campus Can Ruti, 08916 Badalona, Spain; (R.D.-A.); (A.G.-M.); (P.T.-M.)
- Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina, 08303 Mataró, Spain
| | - Juan José Soriano-Raya
- Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB), Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; (A.B.-G.); (M.A.); (D.A.); (S.P.); (J.J.S.-R.); (M.V.); (I.C.C.)
- Institut de Neurociències, Universitat de Barcelona, Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain
| | - Marc Via
- Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB), Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; (A.B.-G.); (M.A.); (D.A.); (S.P.); (J.J.S.-R.); (M.V.); (I.C.C.)
- Institut de Neurociències, Universitat de Barcelona, Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain
- Institut de Recerca Sant Joan de Déu Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain
| | - Imma C. Clemente
- Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB), Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; (A.B.-G.); (M.A.); (D.A.); (S.P.); (J.J.S.-R.); (M.V.); (I.C.C.)
- Institut de Neurociències, Universitat de Barcelona, Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain
- Institut de Recerca Sant Joan de Déu Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain
| | - Alberto García-Molina
- Institut de Recerca Germans Trias i Pujol (IGTP), Campus Can Ruti, 08916 Badalona, Spain; (R.D.-A.); (A.G.-M.); (P.T.-M.)
- Institut Guttmann, Universitat Autònoma de Barcelona, 08916 Badalona, Spain
| | - Maria José Durà Mata
- Servei de Rehabilitació, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, 08916 Badalona, Spain; (M.B.); (M.J.D.M.)
- Institut de Recerca Germans Trias i Pujol (IGTP), Campus Can Ruti, 08916 Badalona, Spain; (R.D.-A.); (A.G.-M.); (P.T.-M.)
| | - Pere Torán-Monserrat
- Institut de Recerca Germans Trias i Pujol (IGTP), Campus Can Ruti, 08916 Badalona, Spain; (R.D.-A.); (A.G.-M.); (P.T.-M.)
- Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina, 08303 Mataró, Spain
- Grup de REcerca Multidisciplinar en Salut i Societat (GREMSAS), 08303 Mataró, Spain
- Department of Medicine, Faculty of Medicine, Universitat de Girona, 17003 Girona, Spain
| | - Kirk I. Erickson
- Advent Health Research Institute, Neuroscience, Orlando, FL 32803, USA;
- Department of Psychology, University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - Maria Mataró
- Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB), Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; (A.B.-G.); (M.A.); (D.A.); (S.P.); (J.J.S.-R.); (M.V.); (I.C.C.)
- Institut de Neurociències, Universitat de Barcelona, Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain
- Institut de Recerca Sant Joan de Déu Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain
| |
Collapse
|
2
|
Hall P, da Cruz Peniche P, Hickey J, Lennon O. Identifying mediators of healthy lifestyle adoption after stroke: a focus group study using a Theoretical Domains Framework guided analysis. BMC Neurol 2025; 25:135. [PMID: 40175889 PMCID: PMC11963367 DOI: 10.1186/s12883-025-04144-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Accepted: 03/19/2025] [Indexed: 04/04/2025] Open
Abstract
BACKGROUND Lifestyle measures in addition to pharmacotherapy are recommended to optimise stroke secondary prevention. Adopting and sustaining good health behaviours after stroke necessitates ongoing motivation, influenced by complex social and cultural factors. This study analysed stroke survivors' experiences of addressing their lifestyle-related risks through a comprehensive theoretical lens addressing cognitive, affective, social, and environmental influences. Patient and public involvement (PPI) enhanced the research quality and transparency. METHODS Eight focus group discussions (N = 35 stroke participants; N = 3 family members/informal carers) were facilitated using semi-structured questions co-developed with a PPI panel. Purposive sampling ensured adequate representation (e.g. urban/rural location and stroke-related disabilities). Data were first coded and categorised inductively and mapped to the Theoretical Domains Framework (TDF) deductively to identify relevant constructs and theories of behaviour-change. RESULTS Participants reported risk reducing lifestyle changes as largely self-directed activities they figured out themselves. Their experiences mapped to 10 of the 14 theoretical domains of the TDF. The most reported behaviour-change mediators discussed were in the domains of Knowledge and Social Influences, seen as encouraging change and supporting emotional reactions. Goals were discussed in a limited way indicating underutilisation. Reminders, reinforcements, and rules to observe for maintaining healthy behaviours, mapping to the Reinforcement and Behavioural Regulation domains, were valued constructs. Psychosocial challenges, emotional responses and cognitive difficulties (Memory, Attention & Decision Processes and Emotions domains) were strongly evident, resonating with the experiences of our PPI contributor and interfacing with behaviour change processes and knowledge uptake. Health-beliefs, self-identity and perceived ability to change behaviour were considered to assert both positive and negative influences on behaviours, mapping to Social/Professional Role & Identity, Beliefs about Consequences and Beliefs about Capabilities domains. 'Know how' was highlighted as largely lacking for behaviour change, with the associated theoretical domains Intentions, Skills, Environmental context & resources to encourage skills development and Optimism about change notably absent from discussions. CONCLUSIONS The TDF proved a valuable tool to link stroke survivors' secondary prevention experiences and unmet needs with recognised constructs for behaviour-change. Results have important theory-driven implications to guide future interventions designed to support individuals in risk reducing behaviours following stroke.
Collapse
Affiliation(s)
- Patricia Hall
- School of Public Health, Physiotherapy and Sports Science, Health Science Centre, University College Dublin, Dublin, Ireland.
- iPASTAR (Improving Pathways for Acute Stroke and Rehabilitation) Collaborative Doctoral Award, Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
| | - Paula da Cruz Peniche
- Department of Physiotherapy, Escola de Educação Física, Fisioterapia e Terapia Ocupacional, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - Julianne Hickey
- iPASTAR (Improving Pathways for Acute Stroke and Rehabilitation) Collaborative Doctoral Award, Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
- iPASTAR PPI Champion, Dublin, Ireland
| | - Olive Lennon
- School of Public Health, Physiotherapy and Sports Science, Health Science Centre, University College Dublin, Dublin, Ireland
| |
Collapse
|
3
|
Li M, Lo WY, Hu Y, Wang S, Sun TC, Temesgen WA, He M, Li Y. Mindfulness- and acceptance-based interventions for people with spinal cord injury: a scoping review. Spinal Cord 2025; 63:159-170. [PMID: 40011744 DOI: 10.1038/s41393-025-01068-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2024] [Revised: 02/06/2025] [Accepted: 02/12/2025] [Indexed: 02/28/2025]
Abstract
STUDY DESIGN Scoping review. OBJECTIVE To synthesize the effects of mindfulness- and acceptance-based interventions (MABIs) on health-related outcomes of individuals with spinal cord injury. SETTING The included studies were conducted across four countries: The United States, Iran, China, and The United Kingdom. METHODS This review followed the Arksey and O'Malley framework and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guideline. Seven databases were searched until November 2024 to identify studies published in English-language that evaluated MABIs' effects on health-related outcomes in people with spinal cord injury. Literature screening, data extraction, and quality assessment were conducted by two reviewers independently. A narrative data synthesis was conducted. RESULTS Of 2389 records, nine studies were included with designs of randomized controlled trials (n = 4), quasi-experimental studies (n = 3), and case studies (n = 2). Acceptance commitment therapy (n = 4) and mindfulness-based interventions (n = 5) were employed. MABIs demonstrated significant improvements in psychological health outcomes (depression, n = 3; anxiety, n = 3; stress, n = 2) with medium-to-large effect sizes (η p 2 = 0.112 - 0.223 ) and other health-related outcomes (chronic pain, n = 1; functional independence, n = 1; engagement in meaningful activities, n = 1; and quality of life, n = 1). Participants found the MABIs to be acceptable and satisfactory. Study quality varied from weak (n = 6) to strong (n = 2). CONCLUSIONS The findings generally support the acceptability and effectiveness of MABIs for improving the overall well-being of individuals with SCI. Future research directions regarding designing MABIs and exploring effectiveness mechanisms were recommended for maximizing its benefits.
Collapse
Affiliation(s)
- Mengqi Li
- School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Wing Yiu Lo
- School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Yule Hu
- School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Shanshan Wang
- School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Tsz-Ching Sun
- School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | | | - Mengting He
- School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Yan Li
- School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.
| |
Collapse
|
4
|
Glavå G, Johansson B. Mindfulness-based stress reduction as perceived by individuals with pathological mental fatigue after an acquired brain injury. Sci Rep 2025; 15:6680. [PMID: 39994249 PMCID: PMC11850794 DOI: 10.1038/s41598-025-90452-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Accepted: 02/13/2025] [Indexed: 02/26/2025] Open
Abstract
After acquired brain injury (ABI), some individuals suffer from long-term fatigue and emotional distress, which affects their work ability and daily life. Mindfulness-based stress reduction (MBSR) has shown promising results in quantitative studies as a complementary treatment for pathological mental fatigue (PMF) after ABI. This study aims to explore how people suffering from lasting PMF after ABI experience MBSR in relation to their PMF, with the intention of better meeting the rehabilitation needs of those affected. Seven individuals (mean age 42 years) who had suffered from long-lasting PMF after ABI took part in the study. None of them had resumed work due to their PMF, but all had recovered from neurological impairments. They were interviewed after completing an MBSR course. Thematic analysis of the participants' perspectives suggested that the MBSR program provided them with coping techniques for living with PMF. They gained a deeper understanding of their condition becoming more self-compassionate, and the treatment provided them with a forum for meeting and sharing experiences with others with similar problems. The qualitative results strengthen the evidence for MBSR as a feasible psychoeducative complementary treatment for PMF after ABI.
Collapse
Affiliation(s)
- Gustaf Glavå
- Department of Psychology, University of Gothenburg, Box 500, Gothenburg, 40530, Sweden.
| | - Birgitta Johansson
- Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, University of Gothenburg, Gothenburg, Sweden
- Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
| |
Collapse
|
5
|
Eapen BC, Tran J, Ballard-Hernandez J, Buelt A, Hoppes CW, Matthews C, Pundik S, Reston J, Tchopev Z, Wayman LM, Koehn T. Stroke Rehabilitation: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Ann Intern Med 2025; 178:249-268. [PMID: 39832369 DOI: 10.7326/annals-24-02205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2025] Open
Abstract
DESCRIPTION In July 2024, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DOD) released a joint update of their 2019 clinical practice guideline (CPG) for the management of stroke rehabilitation. This synopsis is a condensed version of the 2024 CPG, highlighting the key aspects of the guideline development process and describing the major recommendations. METHODS The VA/DOD Evidence-Based Practice Work Group convened a joint VA/DOD guideline development work group (WG) that included clinical stakeholders and conformed to the Institute of Medicine's tenets for trustworthy CPGs. The guideline WG conducted a patient focus group, developed key questions, and systematically searched and evaluated the literature (English-language publications from 1 July 2018 to 2 May 2023). The GRADE (Grading of Recommendations Assessment, Development and Evaluation) system was used to evaluate the evidence. The WG developed 47 recommendations along with algorithms for stroke rehabilitation in the inpatient and outpatient settings. Stakeholders outside the WG reviewed the CPG before approval by the VA/DOD Evidence-Based Practice Work Group. RECOMMENDATIONS This synopsis summarizes where evidence is strongest to support guidelines in crucial areas relevant to primary care physicians: transition to community (case management, psychosocial or behavioral interventions); motor therapy (task-specific practice, mirror therapy, rhythmic auditory stimulation, electrical stimulation, botulinum toxin for spasticity); dysphagia, aphasia, and cognition (chin tuck against resistance, respiratory muscle strength training); and mental health (selective serotonin reuptake inhibitor use, psychotherapy, mindfulness-based therapies for treatment but not prevention of depression).
Collapse
Affiliation(s)
- Blessen C Eapen
- Physical Medicine and Rehabilitation Services, Veterans Affairs Greater Los Angeles Health Care, and Division of Physical Medicine and Rehabilitation, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California (B.C.E.)
| | - Johanna Tran
- Comprehensive Integrated Inpatient Rehabilitation Program, James A. Haley Veterans' Hospital, Tampa, Florida (J.T.)
| | - Jennifer Ballard-Hernandez
- Evidence-Based Practice, Office of Quality and Patient Safety, Veterans Affairs Central Office, Washington, DC (J.B.-H., L.M.W.)
| | - Andrew Buelt
- Bay Pines Veterans Affairs Healthcare System, Bay Pines, Florida (A.B.)
| | - Carrie W Hoppes
- Army-Baylor University Doctoral Program in Physical Therapy, San Antonio, Texas (C.W.H.)
| | - Christine Matthews
- Audiology and Speech Pathology, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (C.M.)
| | - Svetlana Pundik
- Case Western Reserve University School of Medicine and Veterans Affairs Northeast Ohio Healthcare System, Cleveland, Ohio (S.P.)
| | | | - Zahari Tchopev
- 59th Medical Wing, U.S. Air Force, Wilford Hall Ambulatory Surgical Center, San Antonio, Texas (Z.T.)
| | - Lisa M Wayman
- Evidence-Based Practice, Office of Quality and Patient Safety, Veterans Affairs Central Office, Washington, DC (J.B.-H., L.M.W.)
| | - Tyler Koehn
- 959 Medical Operations Squadron, U.S. Air Force, Department of Neurology, Brooke Army Medical Center, San Antonio, Texas (T.K.)
| |
Collapse
|
6
|
Yi Y, Zhao W, Lv S, Zhang G, Rong Y, Wang X, Yang J, Li M. Effectiveness of non-pharmacological therapies for treating post-stroke depression: A systematic review and network meta-analysis. Gen Hosp Psychiatry 2024; 90:99-107. [PMID: 39084147 DOI: 10.1016/j.genhosppsych.2024.07.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Revised: 07/19/2024] [Accepted: 07/20/2024] [Indexed: 08/02/2024]
Abstract
OBJECTIVE Post-stroke depression (PSD) is a common neurological and psychiatric sequelae following a stroke, often surpassing the primary effects of the stroke due to its strong correlation with high mortality rates. In recent years, non-pharmacological therapy has garnered significant attention as a supplementary treatment for PSD, becoming widely adopted in clinical practice. However, the efficacy of specific intervention strategies remains unclear. This study aimed to conduct a network meta-analysis (NMA) of published studies to compare the efficacy of different non-pharmacological therapies for treating PSD. METHOD We systematically searched five databases from inception through March 2024 to identify randomized controlled trials (RCTs) evaluating non-pharmacological therapies for the treatment of PSD. We considered individual intervention and intervention class. Intervention classes included traditional Chinese medicine (TCM), non-invasive electrotherapy stimulation (NIES), psychotherapy (PT), exercise therapy, hyperbaric oxygen, and combined interventions. The NMA was conducted using R and Stata software, following a frequency-based methodology. Assessment of methodological quality and risk of bias was conducted using the Risk of Bias assessment tool 2.0. Therapies were ranked using the P-score, and box-plots visualization, meta-regression, and sensitivity analysis, were performed to assess transitivity, heterogeneity, and consistency, respectively. RESULTS The NMA included 43 studies with a total of 3138 participants. Random-effects models revealed significant efficacy for acupuncture (ACUP) (P-score = 0.92; pooled standardized mean difference (95% CI): -3.12 (-4.63 to -1.60)) and transcranial direct current stimulation (P-score = 0.85; -2.78 (-5.06 to -0.49)) compared to the treatment as usual (TAU) group. In categorical comparisons, TCM_PT (P-score = 0.82; -1.91 (-3.54 to -0.28)), TCM (P-score = 0.79; -1.65 (-2.33 to -0.97)), and NIES (P-score = 0.74; -1.54 (-2.62 to -0.46)) showed significant differences compared to TAU group. Furthermore, our results indicated no significant difference between PT and the control groups. However, Confidence in Network Meta-Analysis results indicated very low overall evidence grade. CONCLUSION Limited evidence suggests that ACUP may be the most effective non-pharmacological therapy for improving PSD, and TCM_PT is the best intervention class. However, the evidence quality is very low, underscoring the need for additional high-quality RCTs to validate these findings, particularly given the limited number of RCTs available for each therapy.
Collapse
Affiliation(s)
- Yunhao Yi
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
| | - Weijie Zhao
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
| | - Shimeng Lv
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
| | - Guangheng Zhang
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
| | - Yuanhang Rong
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
| | - Xin Wang
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
| | - Jingrong Yang
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
| | - Ming Li
- Office of Academic Affairs, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
| |
Collapse
|
7
|
Jaywant A, Keenan A. Pathophysiology, Assessment, and Management of Post-Stroke Cognitive Impairment, Depression, and Fatigue. Phys Med Rehabil Clin N Am 2024; 35:463-478. [PMID: 38514230 DOI: 10.1016/j.pmr.2023.06.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/23/2024]
Abstract
Post-stroke cognitive impairment, depression, and fatigue are common, persistent, and disabling. This review summarizes current knowledge on the pathophysiology, assessment, and management of these debilitating neuropsychiatric sequelae of stroke. We briefly review evolving knowledge on the neural mechanisms and risk factors for each condition. We describe patient-reported outcome measures and clinician rating techniques that can be used to assist in screening and comprehensive assessment. We then discuss behavioral and pharmacologic management strategies. Heterogeneity of stroke remains a challenge in management and new research is still needed to optimize and personalize treatments for stroke survivors.
Collapse
Affiliation(s)
- Abhishek Jaywant
- Department of Psychiatry, Weill Cornell Medicine, 525 East 68th Street, New York, NY 10065, USA; Department of Rehabilitation Medicine, Weill Cornell Medicine, 525 East 68th Street, New York, NY 10065, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10065, USA.
| | - Alexandra Keenan
- Department of Rehabilitation Medicine, Weill Cornell Medicine, 525 East 68th Street, New York, NY 10065, USA
| |
Collapse
|
8
|
Hall P, Lawrence M, Blake C, Lennon O. Interventions for Behaviour Change and Self-Management of Risk in Stroke Secondary Prevention: An Overview of Reviews. Cerebrovasc Dis 2023; 53:1-13. [PMID: 37231867 DOI: 10.1159/000531138] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2023] [Accepted: 05/09/2023] [Indexed: 05/27/2023] Open
Abstract
INTRODUCTION Optimised secondary prevention strategies that include lifestyle change are recommended after stroke. While multiple systematic reviews (SRs) address behaviour change interventions, intervention definitions, and associated outcomes differ between reviews. This overview of reviews addresses the pressing need to synthesise high-level evidence for lifestyle-based behavioural and/or self-management interventions to reduce risk in stroke secondary prevention in a structured, consistent way. METHODS Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria were applied to meta-analyses, demonstrating statistically significant effect sizes to establish the certainty of existing evidence. Electronic databases MEDLINE, Embase, Epistemonikos, and the Cochrane Library of Systematic Reviews were systematically searched, current to March 2023. RESULTS Fifteen SRs were identified following screening, with moderate overlap of primary studies demonstrated (5.84% degree of corrected covered area). Interventions identified could be broadly categorised as multimodal; behavioural change; self-management; psychological talk therapies, albeit with overlap between some theoretical domains. Seventy-two meta-analyses addressing twenty-one preventive outcomes of interest were reported. Best-evidence synthesis identifies that for primary outcomes of mortality and future cardiovascular events post-stroke, moderate certainty GRADE evidence supports multimodal interventions to reduce cardiac events, with no available evidence for outcomes of mortality (all-cause or cardiovascular) or recurrent stroke events. For secondary outcomes addressing risk-reducing behaviours, best-evidence synthesis identifies moderate certainty GRADE evidence for multimodal lifestyle-based interventions to increase physical activity participation, and low certainty GRADE evidence for behavioural change interventions to improve healthy eating post-stroke. Similarly, low certainty GRADE evidence supports self-management interventions to improve preventive medication adherence. For mood self-management post-stroke, moderate GRADE evidence supports psychological therapies for remission and/or reduction of depression and low/very low certainty GRADE evidence for reduction of psychological distress and anxiety. Best-evidence for outcomes addressing proxy physiological measures identified low GRADE evidence supporting multimodal interventions to improve blood pressure, waist circumference, and LDL cholesterol. CONCLUSION Effective strategies to redress risk-related health behaviours are required in stroke survivors to complement current pharmacological secondary prevention. Inclusion of multimodal interventions and psychological talk therapies in evidence-based stroke secondary prevention programmes is warranted given the moderate GRADE of evidence that supports their role in risk reduction. Given the overlap in primary studies across reviews, often with overlapping theoretical domains between broad intervention categories, further research is required to identify optimal intervention behavioural change theories and techniques employed in behavioural/self-management interventions.
Collapse
Affiliation(s)
- Patricia Hall
- iPASTAR CDA Programme, Division of Population Health Sciences, RCSI, Dublin, Ireland
- School of Public Health, Physiotherapy and Sports Science, UCD, Dublin, Ireland
| | - Maggie Lawrence
- Department of Nursing and Community Health, GCU, G4 0BA Glasgow, Glasgow, UK
| | - Catherine Blake
- School of Public Health, Physiotherapy and Sports Science, UCD, Dublin, Ireland
| | - Olive Lennon
- School of Public Health, Physiotherapy and Sports Science, UCD, Dublin, Ireland
| |
Collapse
|